A highly conserved processed PTEN pseudogene is located on chromosome band 9p21

Altered PTEN Expression as a Diagnostic Marker for the Earliest Endometrial Precancers

Mutter, G. L. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.11.924 · Cited by 829 · see citing works

Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation.

Soria, J., Lee, H., Lee, J. I., Luo, W., Issa, J. J., Kemp, B. L., Liu, D. D., Kurie, J. M., Mao, L., & Khuri, F. R. (2002) · PubMed · Cited by 406 · see citing works

Vertebrate pseudogenes

Mighell, A. J., Smith, N., Robinson, P. A., & Markham, A. F. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01199-6 · Cited by 403 · see citing works

Novel PTEN mutations in patients with Cowden disease: absence of clear genotype–phenotype correlations

Nelen, M. R., Kremer, H., Konings, I. B. M., Schoute, F., van Essen, A. J., Koch, R., Woods, C. G., Fryns, J., Hamel, B. C. J., Hoefsloot, L. H., et al. (1999) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200289 · Cited by 350 · see citing works

Deficiency of PTEN in Jurkat T Cells Causes Constitutive Localization of Itk to the Plasma Membrane and Hyperresponsiveness to CD3 Stimulation

Shan, X., Czar, M. J., Bunnell, S. C., Liu, P., Liu, Y., Schwartzberg, P. L., & Wange, R. L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.18.6945-6957.2000 · Cited by 341 · see citing works

PTEN/PTENP1: ‘Regulating the regulator of RTK-dependent PI3K/Akt signalling’, new targets for cancer therapy

Haddadi, N., Lin, Y., Travis, G., Simpson, A. M., Nassif, N. T., & McGowan, E. M. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0803-3 · Cited by 314 · see citing works

PTEN, a unique tumor suppressor gene.

Dahia, P. L. M. (2000) · Endocrine Related Cancer · doi:10.1677/erc.0.0070115 · Cited by 279 · see citing works

PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanismsin haematological malignancies

Dahia, P. L. M. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.2.185 · Cited by 270 · see citing works

A comprehensive genomic pan-cancer classification using The Cancer Genome Atlas gene expression data

Li, Y., Kang, K., Krahn, J. M., Croutwater, N., Lee, K. C., Umbach, D. M., & Li, L. (2017) · BMC Genomics · doi:10.1186/s12864-017-3906-0 · Cited by 227 · see citing works

Promoter methylation of the PTEN gene is a common molecular change in breast cancer

García, J. M., Silva, J., Peña, C., García‐Barberán, V., Rodríguez, R., Cruz, M. Á., Cantos, B., Provencio, M., España, P., & Bonilla, F. (2004) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20062 · Cited by 224 · see citing works

Pten signaling in gliomas

Knobbe-Thomsen, C. B., Merlo, A. U., & Reifenberger, G. (2002) · Neuro-Oncology · doi:10.1093/neuonc/4.3.196 · Cited by 203 · see citing works

Stabilization and productive positioning roles of the C2 domain of PTEN tumor suppressor.

Georgescu, M. M., Kirsch, K. H., Kaloudis, P., Yang, H., Pavletich, N. P., & Hanafusa, H. (2000) · PubMed · Cited by 176 · see citing works

Genomes were forged by massive bombardments with retroelements and retrosequences

Brosius, J. (2000) · Springer eBooks · doi:10.1007/978-94-011-4156-7_23 · Cited by 171 · see citing works

PTEN Is a Target of Chromosome 10q Loss in Anaplastic Oligodendrogliomas and PTEN Alterations Are Associated with Poor Prognosis

Sasaki, H., Ƶlatescu, M. C., Betensky, R. A., Ino, Y., Cairncross, J. G., & Louis, D. N. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61702-6 · Cited by 157 · see citing works

PTEN, a Protean Tumor Suppressor

Mutter, G. L. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64656-1 · Cited by 147 · see citing works

Somatic mutation of PTEN in bladder carcinoma

Aveyard, J. S., Skilleter, A., Habuchi, T., & Knowles, M. A. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690439 · Cited by 137 · see citing works

PTEN methylation and expression in glioblastomas

Baeza, N., Weller, M., Yonekawa, Y., Kleihues, P., & Ohgaki, H. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0748-4 · Cited by 134 · see citing works

Genomes were forged by massive bombardments with retroelements and retrosequences

Brosius, J. (1999) · Genetica · doi:10.1023/a:1004018519722 · Cited by 131 · see citing works

Protein tyrosine phosphatases

Mustelin, T. (2002) · Frontiers in bioscience · doi:10.2741/a770 · Cited by 121 · see citing works

Evidence That SHIP-1 Contributes to Phosphatidylinositol 3,4,5-Trisphosphate Metabolism in T Lymphocytes and Can Regulate Novel Phosphoinositide 3-Kinase Effectors

Freeburn, R. W., Wright, K. L., Burgess, S., Astoul, E., Cantrell, D. A., & Ward, S. G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5441 · Cited by 121 · see citing works

PTEN promoter is methylated in a proportion of invasive breast cancers

Khan, S., Kumagai, T., Vora, J., Bose, N., Sehgal, I., Koeffler, H. P., & Bose, S. (2004) · International Journal of Cancer · doi:10.1002/ijc.20447 · Cited by 120 · see citing works

Considerations When Analyzing the Methylation Status of PTEN Tumor Suppressor Gene

Zysman, M., Chapman, W. B., & Bapat, B. V. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64902-4 · Cited by 110 · see citing works

Silencing of the PTEN tumor‐suppressor gene in anaplastic thyroid cancer

Frisk, T., Foukakis, T., Dwight, T., Lundberg, J., Höög, A., Wallin, G., Eng, C., Zedenius, J., & Larsson, C. (2002) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10098 · Cited by 104 · see citing works

The complexity of PTEN: mutation, marker and potential target for therapeutic intervention

Steelman, L. S., Bertrand, F. E., & McCubrey, J. A. (2004) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.8.6.537 · Cited by 99 · see citing works

Genetic insights into familial cancers – update and recent discoveries

Marsh, D. J., & Zori, R. T. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00023-x · Cited by 94 · see citing works

A transcribed pseudogene of MYLK promotes cell proliferation

Han, Y. J., Ma, S. F., Yourek, G., Park, Y., & Garcia, J. G. N. (2011) · The FASEB Journal · doi:10.1096/fj.10-177808 · Cited by 85 · see citing works

Transcriptional analysis of the PTEN/MMAC1 pseudogene, ΨPTEN

Fujii, G. H., Morimoto, A. M., Berson, A. E., & Bolen, J. B. (1999) · Oncogene · doi:10.1038/sj.onc.1202492 · Cited by 84 · see citing works

Transient ectopic expression of PTEN in thyroid cancer cell lines induces cell cycle arrest and cell type-dependent cell death

Weng, L. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.3.251 · Cited by 82 · see citing works

PTEN Expression in Endometrial Biopsies as a Marker of Progression to Endometrial Carcinoma

Lacey, J. V., Mutter, G. L., Ronnett, B. M., Ioffe, O. B., Duggan, M. A., Rush, B. B., Glass, A. G., Richesson, D. A., Chatterjee, N., Langholz, B. M., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1154 · Cited by 80 · see citing works

Mutations of Phosphatase and Tensin Homolog Deleted from Chromosome 10 in Canine Hemangiosarcoma

Dickerson, E. B., Thomas, R. J., Fosmire, S. P., Lamerato-Kozicki, A. R., Bianco, S. R., Wojcieszyn, J. W., Breen, M., Helfand, S. C., & Modiano, J. F. (2005) · Veterinary Pathology · doi:10.1354/vp.42-5-618 · Cited by 80 · see citing works

Expression of the PTEN tumour suppressor protein during human development

Gimm, O. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.11.1633 · Cited by 76 · see citing works

Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas

Freihoff, D., Kempe, A. C., Beste, B., Wappenschmidt, B., Kreyer, E., Hayashi, Y., Meindl, A., Krebs, D., Wiestler, O. D., von Deimling, A., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690121 · Cited by 74 · see citing works

Alterations in PTEN and PIK3CA in colorectal cancers in the EPIC Norfolk study: associations with clinicopathological and dietary factors

Naguib, A., Cooke, J. C., Happerfield, L. C., Kerr, L., Gay, L. J., Luben, R., Ball, R. Y., Mitrou, P. N., McTaggart, A., & Arends, M. J. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-123 · Cited by 73 · see citing works

Current Research on Non-Coding Ribonucleic Acid (RNA)

Wang, J., Samuels, D. C., Zhao, S., Xiang, Y., Zhao, Y., & Guo, Y. P. (2017) · Genes · doi:10.3390/genes8120366 · Cited by 72 · see citing works

Analysis of the SDHD Gene, the Susceptibility Gene for Familial Paraganglioma Syndrome (PGL1), in Pheochromocytomas

Aguiar, R. C. T., Cox, G., Pomeroy, S. L., & Dahia, P. L. M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.6.7547 · Cited by 58 · see citing works

Pseudogene-Expressed RNAs: Emerging Roles in Gene Regulation and Disease

Grandér, D., & Johnsson, P. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_442 · Cited by 56 · see citing works

Decreased expression of pseudogene PTENP1 promotes malignant behaviours and is associated with the poor survival of patients with HNSCC

Liu, J., Xing, Y., Xu, L., Chen, W., Cao, W., & Zhang, C. (2017) · Scientific Reports · doi:10.1038/srep41179 · Cited by 47 · see citing works

Estrogen affects the negative feedback loop of PTENP1-miR200c to inhibit PTEN expression in the development of endometrioid endometrial carcinoma

Chen, R., Zhang, M., Liu, W., Chen, H., Cai, T., Xiong, H., Sheng, X., Liu, S., Peng, J., Wang, F., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1207-4 · Cited by 46 · see citing works

PTEN deficiency is a common defect in juvenile myelomonocytic leukemia

Liu, Y. L., Castleberry, R. P., & Emanuel, P. D. (2008) · Leukemia Research · doi:10.1016/j.leukres.2008.09.036 · Cited by 41 · see citing works

The molecular dynamics of long noncoding RNA control of transcription in PTEN and its pseudogene

Lister, N. C., Shevchenko, G., Walshe, J. L., Groen, J., Johnsson, P., Vidarsdóttir, L., Grandér, D., Ataide, S. F., & Morris, K. V. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1621490114 · Cited by 38 · see citing works

Network of Cancer Genes: a web resource to analyze duplicability, orthology and network properties of cancer genes

Syed, A. S., D’Antonio, M., & Ciccarelli, F. D. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp957 · Cited by 36 · see citing works

Overexpression of lncRNA PTENP1 suppresses glioma cell proliferation and metastasis in vitro

Hu, S., Xu, L., Li, L., Luo, D., Zhao, H., Li, D., & Peng, B. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s182537 · Cited by 35 · see citing works

The pseudogene PTENP1 regulates smooth muscle cells as a competing endogenous RNA

Lai, Y., Li, J., Zhong, L., He, X. F., Si, X., Sun, Y., Chen, Y., Zhong, J., Hu, Y., Li, B., et al. (2019) · Clinical Science · doi:10.1042/cs20190156 · Cited by 35 · see citing works

Next-Generation Sequencing–Based Detection of Germline Copy Number Variations in BRCA1 / BRCA2

Schmidt, A. Y., Hansen, T. V. O., Ahlborn, L. B., Jønson, L., Yde, C. W., & Nielsen, F. C. (2017) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2017.07.003 · Cited by 32 · see citing works

PTEN expression is maintained in sporadic colorectal tumours

Taniyama, K., Steve Goodison, B., Ito, R., Bookstein, R., Miyoshi, N., 田原, 榮., Tarin, D., & Urquidi, V. (2001) · The Journal of Pathology · doi:10.1002/path.908 · Cited by 32 · see citing works

PTEN, PTENP1, microRNAs, and ceRNA Networks: Precision Targeting in Cancer Therapeutics

Travis, G., McGowan, E. M., Simpson, A. M., Marsh, D. J., & Nassif, N. T. (2023) · Cancers · doi:10.3390/cancers15204954 · Cited by 31 · see citing works

Divergent Activity of the Pseudogene PTENP1 in ER-Positive and Negative Breast Cancer

Yndestad, S., Austreid, E., Skaftnesmo, K. O., Lønning, P. E., & Eikesdal, H. P. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0207 · Cited by 30 · see citing works

Evidence of a possible epigenetic inactivation mechanism operating on a region of mouse chromosome 19 in γ-radiation-induced thymic lymphomas

Santos, J., Herranz, M., Fernández, M., Vaquero, C., López, P., & Fernández‐Piqueras, J. (2001) · Oncogene · doi:10.1038/sj.onc.1204297 · Cited by 30 · see citing works

A reinvestigation of somatic hypermethylation at the PTEN CpG island in cancer cell lines

Hesson, L. B., Packham, D., Pontzer, E., Funchain, P., Eng, C., & Ward, R. L. (2012) · Biological Procedures Online · doi:10.1186/1480-9222-14-5 · Cited by 27 · see citing works

Revisiting the Clinical and Biologic Relevance of Partial PTEN Loss in Melanoma

Giles, K. M., Rosenbaum, B. E., Berger, M., Izsak, A., Li, Y., Bochaca, I. I., de Miera, E. V., Wang, J., Darvishian, F., Zhong, J., et al. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.07.031 · Cited by 27 · see citing works

Mutation Analysis of the Putative Tumor Suppressor Gene PTEN/MMAC1 in Cervical Cancer

Su, T.-H., Chang, J.-G., Perng, L.-I., Chang, C., Wei, H., Wang, N. M., & Tsai, C. (2000) · Gynecologic Oncology · doi:10.1006/gyno.1999.5659 · Cited by 27 · see citing works

The PTENP1 Pseudogene, Unlike the PTEN Gene, Is Methylated in Normal Endometrium, As Well As in Endometrial Hyperplasias and Carcinomas in Middle-Aged and Elderly Females

Kovalenko, T. F., Morozova, K. V., Ozolinya, L. A., Лапина, И. А., & Patrushev, L. I. (2018) · Acta Naturae · doi:10.32607/20758251-2018-10-1-43-50 · Cited by 26 · see citing works

Expression of PTEN in malignant and non‐malignant human prostate tissues: comparison with p27 protein expression

Fenic, I., Franke, F. E., Failing, K., Steger, K., & Woenckhaus, J. (2004) · The Journal of Pathology · doi:10.1002/path.1545 · Cited by 26 · see citing works

PTEN Mutation Analysis in Two Genetic Subtypes of High-Grade Oligodendroglial Tumors

Jeuken, J. W. M., Nelen, M. R., Vermeer, H., van Staveren, W. C. G., Kremer, H., van Overbeeke, J. J., & Boerman, R. H. (2000) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(99)00210-1 · Cited by 25 · see citing works

Activation of a Cryptic Splice Site of PTEN and Loss of Heterozygosity in Benign Skin Lesions in Cowden Disease

Meltzer, S. J., Wolter, M., Trojan, J., Plotz, G., Brieger, A., Raedle, J., & Zeuzem, S. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01954.x · Cited by 23 · see citing works

Efficient genetic editing of human intestinal organoids using ribonucleoprotein-based CRISPR

Skoufou-Papoutsaki, N., Adler, S., D'Santos, P., Mannion, L., Mehmed, S., Kemp, R., Smith, A., Perrone, F., Nayak, K., Russell, A., et al. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.050279 · Cited by 22 · see citing works

Metastasis associated long noncoding RNAs in glioblastoma: Biomarkers and therapeutic targets

Yadav, G., & Kulshreshtha, R. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30577 · Cited by 22 · see citing works

True

Hamilton, J. A., Stewart, L. M. D., Gray, I. C., Gray, N. E., Roberts, K. G., Watson, G., Snary, D., Ajayi, L., & Kaisary, A. V. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1211 · Cited by 22 · see citing works

Investigation of PTEN promoter methylation in ameloblastoma

Lapthanasupkul, P., Klongnoi, B., Mutirangura, A., & Kitkumthorn, N. (2020) · Medicina oral, patología oral y cirugía bucal · doi:10.4317/medoral.23498 · Cited by 21 · see citing works

Expression and mutation analyses of MKK4, a candidate tumour suppressor gene encoded by chromosome 17p, in human gastric adenocarcinoma

Chae, K. S., Ryu, B.-K., Lee, M.-G., Byun, D., & Chi, S.-G. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00147-8 · Cited by 19 · see citing works

A study on promoter methylation of PTEN in sporadic breast cancer patients from North India

Siddiqui, S., Akhter, N., Deo, S. V. S., Shukla, N. K., & Husain, S. A. (2016) · Breast Cancer · doi:10.1007/s12282-015-0665-0 · Cited by 18 · see citing works

Pten signaling in gliomas

Knobbe-Thomsen, C. B., Merlo, A. U., & Reifenberger, G. (2002) · Neuro-Oncology · doi:10.1215/s1522851702000029 · Cited by 18 · see citing works

Detection of PTEN nonsense mutation and ψPTEN expression in central nervous system high-grade astrocytic tumors by a yeast-based stop codon assay

Zhang, C. L., Tada, M., Kobayashi, H., Nozaki, M., Moriuchi, T., & Abe, H. (2000) · Oncogene · doi:10.1038/sj.onc.1203795 · Cited by 17 · see citing works

Current research on head and neck cancer-associated long noncoding RNAs

Song, W., Sun, Y., Lin, J., & Bi, X. (2017) · Oncotarget · doi:10.18632/oncotarget.22608 · Cited by 16 · see citing works

PTEN and Egr-1 expression in thyroid proliferative lesions

Loreto, C. D., Tell, G., Pestrin, M., Pandolfi, M., Damante, G., & Puglisi, F. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.10.014 · Cited by 16 · see citing works

The Complex Landscape of PTEN mRNA RegulationPreprint

Sellars, E., Gabra, M., & Salmena, L. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a036236 · Cited by 16 · see citing works

Serum insulin-like growth factor-I and breast cancer

Toniolo, P. G., Bruning, P. F., Akhmedkhanov, A., Bonfrèr, J. M. G., Koenig, K. L., Lukanova, A., Shore, R. E., & Zeleniuch‐Jacquotte, A. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20001201)88:5 · Cited by 341 · see citing works

PTEN and MXI1 allelic loss on chromosome 10q is rare in melanoma in vivo

Herbst, R. A., Podewski, E. K., Mommert, S., Kapp, A., & Weiss, J. M. (1999) · Archives of Dermatological Research · doi:10.1007/s004030050456 · Cited by 15 · see citing works

Pseudogenes in gastric cancer pathogenesis: a review article

Emadi‐Baygi, M., Sedighi, R., Nourbakhsh, N., & Nikpour, P. (2017) · Briefings in Functional Genomics · doi:10.1093/bfgp/elx004 · Cited by 14 · see citing works

Phosphatase and tensin homolog is a differential diagnostic marker between nonalcoholic and alcoholic fatty liver disease

Sanchez-Pareja, A., Clément, S., Peyrou, M., Spahr, L., Negro, F., Rubbia‐Brandt, L., & Foti, M. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i14.3735 · Cited by 13 · see citing works

Alterations of 9p in squamous cell carcinoma and adenocarcinoma of the lung: association with smoking, TP53, and survival

Marsit, C. J., Wiencke, J. K., Nelson, H. H., Kim, D., Hinds, P. W., Aldape, K., & Kelsey, K. T. (2005) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2005.04.001 · Cited by 11 · see citing works

Toward Systems Pathology for PTEN DiagnosticsPreprint

Haddadi, N., Travis, G., Nassif, N. T., Simpson, A. M., & Marsh, D. J. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a037127 · Cited by 10 · see citing works

Hamartoma and Lentiginosis Syndromes: Clinical and Molecular Aspects

Marsh, D. J., & Stratakis, C. A. (2001) · KARGER eBooks · doi:10.1159/000061045 · Cited by 8 · see citing works

Recurrent allelic imbalance at the rat Pten locus in DMBA‐induced fibrosarcomas

Sjöling, Å., Samuelson, E., Adamović, T., Behboudi, A., Röhme, D., & Levan, G. (2002) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10143 · Cited by 7 · see citing works

Absence of PTEN/MMAC1 Pseudogene in Mice

Kwabi‐Addo, B., Thompson, T. C., & Ittmann, M. (2000) · DNA and Cell Biology · doi:10.1089/10445490050021212 · Cited by 6 · see citing works

The Role of Non-coding RNAs in the Pathogenesis of Glial Tumors

Kovalenko, T. F., Larionova, T. D., Антипова, Н. В., Shakhparonov, M. I., & Pavlyukov, M. S. (2021) · Acta Naturae · doi:10.32607/actanaturae.11270 · Cited by 5 · see citing works

Rare‐type Mutations of MMAC1 Tumor Suppressor Gene in Human Glioma Cell Lines and Their Tumors of Origin

Zhang, S., 遠藤, 純., Ichikawa, T., Yoshimura, J., Onda, K., Tanaka, R., Washiyama, K., & Kumanishi, T. (1999) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1999.tb00838.x · Cited by 5 · see citing works

Genetics of Cutaneous Malignant Melanoma

Weiss, J. M., Herbst, R. A., & Kapp, A. (1999) · Oncology Research and Treatment · doi:10.1159/000027025 · Cited by 4 · see citing works

Carcinoma tiroideo del epitelio folicular: marcadores tumorales y oncogenes

Álvarez-Núñez, F., Móra, J., Matías‐Guiu, X., & de Leiva, A. (2003) · Medicina Clínica · doi:10.1016/s0025-7753(03)75192-6 · Cited by 3 · see citing works

Publishing Negative Data: -Tubulin Mutations in Lung Cancer

Kaye, F. J. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.24.1832 · Cited by 3 · see citing works

Regulation of antiviral and antitumor immunity by the BRCA1 pseudogene in human cancers

Han, Y. J., Zhang, J., Shariff, M., Wu, S., Khramtsova, G. F., Nguyen, L. C., Peiffer, D. S., Li, N., Lewicka, A., Moore, M., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2528911123 · Cited by 2 · see citing works

Promoter methylation status of PTEN, SYK and survivin genes in breast cancer tissues derived from Chinese women

Lu, X., Gu, Y., Zhu, D., Tan, J., Liu, X., & Zha, X. (2009) · Asian Biomedicine · doi:10.5372/abm.v3i6.264 · Cited by 2 · see citing works

Studying the Oncosuppressive Functions of PTENP1 as a ceRNA

Travis, G., Haddadi, N., Simpson, A. M., Marsh, D. J., McGowan, E. M., & Nassif, N. T. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1503-4_11 · Cited by 2 · see citing works

Primary malignant lymphoma of the brain: analysis of MMAC1 (PTEN) tumor suppressor gene

Ding, X., 遠藤, 純., Zhang, S., Saito, T., Kouno, M., Kuroiwa, T., Washiyama, K., & Kumanishi, T. (2001) · Brain Tumor Pathology · doi:10.1007/bf02479427 · Cited by 2 · see citing works

Basic Concepts in Molecular Pathology

Killeen, A. A. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-431-3_1 · Cited by 1 · see citing works

Emerging Roles of Pseudogene RNAs in Antitumor and Antiviral Immunity

Han, Y. J., Gack, M. U., & Olopade, O. I. (2021) · Journal of Cancer Immunology · doi:10.33696/cancerimmunol.3.045 · Cited by 1 · see citing works

Suppression and activation of lipid signalling in cancer : tumour suppressor PTEN and oncogenic sphingosine kinase

Haddadi, N. (2019) · OPUS - Open Publications of UTS Scholars (University of Technology Sydney) · Cited by 1 · see citing works

Characterization of non-coding RNAs in cancer

Johnsson, P. (2014) · Figshare

The role of the tumor suppressor PTEN in bone homeostasis

Arsenault, M. G. (2008) · eScholarship@McGill (McGill) · doi:10.82308/12655

Investigação molecular dos genes PTEN e DREAM em pacientes portadores de bócio multinodular

Shinzato, A. (2015) · doi:10.11606/d.5.2015.tde-05102015-102433

Struktur und Funktion des Gens für das translationell kontrollierte Tumorprotein (TCTP)

Thiele, H. (2000) · doi:10.18452/14496

Alterations in PTEN and PIK3CA in colorectal cancers in the EPIC Norfolk study

Naguib, A., Cooke, J. C., Happerfield, L. C., Kerr, L., Luben, R., Ball, R. Y., Mitrou, P. N., McTaggart, A., & Arends, M. J. (2016)

Cowden Syndrome

Marsh, D. J., & Zori, R. T. (2004) · Informa Healthcare eBooks · doi:10.3109/9780203997352.061

Genetic and cell biological aspects of PTEN in prostate cancer

van Duijn, P. W. (2008) · RePub (Erasmus University Rotterdam)

Cowden-Syndrom und juvenile Polypose

Hahn, M., Back, W. E., & Schackert, H. K. (2001) · Springer eBooks · doi:10.1007/978-3-642-56889-3_12

Role of long non-coding RNAs in prostate cancer progression

Cipolla, R. (2023) · doi:10.70675/629b8b5dz2fe3z478dz87c4z97664da47d1e

Clinical validation of a high-performance somatic exome sequencing assay: from target-enrichment strategy to variant calling

Tsuji, J., Rickles-Young, M., Abreu, J., Friedman, A., Petersen, C. L., Iorgulescu, J. B., Scheffler, K., O’Connell, T., Heyns, T., Małolepsza, E., et al. (2026) · npj Genomic Medicine · doi:10.1038/s41525-026-00569-w

Identification of a Pseudogene That Can Masquerade as a Mutant Allele of the PTEN/MMAC1 Tumor Suppressor Gene

Whang, Y. E., Wu, X., & Sawyers, C. L. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.11.859 · Cited by 24 · see citing works

Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation

Marsh, D. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.3.507 · Cited by 653 · see citing works

Absence of PTEN/MMAC1 Pseudogene in Mice

Kwabi‐Addo, B., Thompson, T. C., & Ittmann, M. (2000) · DNA and Cell Biology · doi:10.1089/10445490050021212 · Cited by 6 · see citing works

PTEN: Regulation, Signalling and Targeting in Cancer

Kotelevets, L., Scott, M. G. H., & Chastre, E. (2026) · Cancers · doi:10.3390/cancers18091320

PTEN

Yeh, J. J., & Sellers, W. R. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-230-2_10